Welcome to the Journal
h5-index citation: 11 h5-median citation: 16
Journal Impact Factor 1.0* ; 1.93* (5 Year Impact Factor)
International Journal of Clinical Rheumatology is at the cutting edge of the most recent clinical, translational and lab based exploration to propel the treatment for a wide range of rheumatic diseases and disorders which includes themes, for example, treatment, surgery, imaging and clinical education.
The journal is committed to distribute most elevated quality studies identified with clinical determination and administration of rheumatic ailments through facilitated parts of clinical consideration and clinical examination concentrated on propelling treatment and personal satisfaction for individuals with joint pain, immune system infections, bone issue and related conditions. This journal offers an open access platform to Rheumatology community where, the authors can publish all the reliable sources of information on research findings and current developments as original articles, reviews, case studies, clinical images, short communications, commentaries, etc. and all the published materials will be accessed online all over the world without any subscription fee. The journal gives fundamental perusing to rheumatologists and additionally orthopedic specialists, pharmacologists, pathologists, radiologists, general experts and other wellbeing experts with an enthusiasm for patients with rheumatic maladies.
The journal also incorporates original papers inside the assorted fields of rheumatology, clinical experimentation as well as medicine, pathologic process, immunology, immunopathology, microbiology, clinical problems involving joints, soft tissues, auto-immune diseases, heritable connective tissue disorders and different types of radiological studies.
Indexing: Scimago, Excerpta Medica (EMBASE), CAS (Chemical Abstracts Service), SHERPA RoMEO, CNKI, Open J Gate
Submit your manuscripts through Online Manuscript Submission System:
https://www.scholarscentral.org/submissions/international-clinical-rheumatology.html
Contact Editorial Office at [email protected]
Recently Published Articles
Perspective p. 084
COVID catalyst: telemedicine in rheumatology protects patient care beyond just the pandemic
Author(s): Adam Kilian*, Mamata Chand, Maha Almackenzie, Nadine Mbuyi, Saira Bilal, Gelareh Atefi & Victoria K. Shanmugam
During January 2021, rheumatologic care in Washington DC was affected by both the peak of the COVID-19 pandemic in the United States as well as a deadly insurrection and attack on the US Cap..
Short Communication p. 088
Are subdeltoid bursitis and polymyalgia rheumatica preferances of COVID-19 vaccine?
Author(s): Alexander Rozin P*
COVID-19 vaccine became clear card life-saving medication. Due to over world vaccination a rate of prevalence and incidence of coronal infection is going to back down. However, we meet diffe..
Research Article p. 090
Long-term results of joint damage in patients with rheumatoid arthritis treated with abatacept: 5-year results of a clinical observational study
Author(s): Takeshi Mochizuki*, Koichiro Yano2, Katsunori Ikari, Ken Okazaki
Background: In abatacept treatment for RA, there are no studies investigating the long-term results of joint damage in daily clinical practice. We aimed to investigate the long-term efficacy..
Research Article p. 099
Demographic, clinical, and serological features of Iraqi patients with rheumatoid arthritis: evaluation of 470 patients
Author(s): Abdulsatar J. Mathkhor*, Abdulnasser H. Abdullah & Amer S. Khoudhairy
Aim: To evaluate the demographic, clinical, serological, and radiological characteristics of patients with Rheumatoid Arthritis (RA). Methods: This was a cross-sectional, descriptive study ..
